Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Influenza, Human | 16 | 2018 | 126 | 4.030 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 6 | 2018 | 50 | 1.390 |
Why?
|
| Influenza Vaccines | 7 | 2018 | 83 | 1.310 |
Why?
|
| Orthomyxoviridae | 2 | 2014 | 15 | 0.820 |
Why?
|
| Child, Preschool | 18 | 2018 | 1282 | 0.770 |
Why?
|
| Influenza B virus | 4 | 2018 | 20 | 0.670 |
Why?
|
| Pneumococcal Vaccines | 4 | 2015 | 27 | 0.630 |
Why?
|
| Streptococcus pneumoniae | 5 | 2015 | 40 | 0.620 |
Why?
|
| Infant | 14 | 2016 | 1083 | 0.600 |
Why?
|
| Child | 16 | 2018 | 2478 | 0.600 |
Why?
|
| Pneumococcal Infections | 4 | 2015 | 32 | 0.570 |
Why?
|
| Emergency Service, Hospital | 4 | 2016 | 490 | 0.550 |
Why?
|
| Vaccination | 4 | 2018 | 146 | 0.550 |
Why?
|
| Adolescent | 14 | 2018 | 3638 | 0.490 |
Why?
|
| Whooping Cough | 2 | 2012 | 11 | 0.450 |
Why?
|
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 2 | 2012 | 8 | 0.450 |
Why?
|
| Aerosols | 2 | 2013 | 15 | 0.450 |
Why?
|
| Pneumonia, Pneumococcal | 2 | 2013 | 12 | 0.450 |
Why?
|
| Family Characteristics | 2 | 2014 | 37 | 0.440 |
Why?
|
| Age Distribution | 1 | 2014 | 201 | 0.420 |
Why?
|
| North Carolina | 7 | 2016 | 1546 | 0.420 |
Why?
|
| Antibodies, Viral | 1 | 2014 | 65 | 0.410 |
Why?
|
| Immunization | 1 | 2013 | 33 | 0.400 |
Why?
|
| Critical Care | 1 | 2014 | 108 | 0.390 |
Why?
|
| Inhalation Exposure | 1 | 2013 | 10 | 0.390 |
Why?
|
| Air Microbiology | 1 | 2013 | 19 | 0.390 |
Why?
|
| Medical Records | 1 | 2013 | 77 | 0.390 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2012 | 12 | 0.390 |
Why?
|
| Antiviral Agents | 1 | 2013 | 108 | 0.390 |
Why?
|
| Influenza A virus | 1 | 2012 | 24 | 0.390 |
Why?
|
| Immunization Programs | 1 | 2012 | 26 | 0.370 |
Why?
|
| Respiratory Protective Devices | 1 | 2011 | 3 | 0.360 |
Why?
|
| Registries | 1 | 2013 | 315 | 0.360 |
Why?
|
| Eye Infections, Viral | 1 | 2011 | 3 | 0.360 |
Why?
|
| Male | 18 | 2018 | 19641 | 0.340 |
Why?
|
| Humans | 29 | 2018 | 32798 | 0.340 |
Why?
|
| Female | 18 | 2018 | 20261 | 0.340 |
Why?
|
| Primary Health Care | 1 | 2013 | 231 | 0.340 |
Why?
|
| Hospitalization | 2 | 2012 | 488 | 0.320 |
Why?
|
| Young Adult | 7 | 2018 | 2730 | 0.320 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 4 | 2018 | 24 | 0.310 |
Why?
|
| Meningococcal Vaccines | 1 | 2007 | 10 | 0.260 |
Why?
|
| Adult | 8 | 2018 | 9560 | 0.250 |
Why?
|
| Infant, Newborn | 4 | 2016 | 694 | 0.230 |
Why?
|
| Prospective Studies | 6 | 2018 | 2327 | 0.220 |
Why?
|
| Middle Aged | 7 | 2016 | 12125 | 0.210 |
Why?
|
| Middle Ear Ventilation | 2 | 2015 | 9 | 0.210 |
Why?
|
| Haemophilus influenzae | 2 | 2015 | 14 | 0.210 |
Why?
|
| Otitis Media with Effusion | 2 | 2015 | 12 | 0.210 |
Why?
|
| Immunization Schedule | 3 | 2012 | 26 | 0.190 |
Why?
|
| RNA, Viral | 2 | 2013 | 49 | 0.190 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 255 | 0.180 |
Why?
|
| Parents | 2 | 2012 | 148 | 0.170 |
Why?
|
| Time Factors | 3 | 2015 | 2183 | 0.160 |
Why?
|
| Otitis Media | 2 | 2015 | 23 | 0.160 |
Why?
|
| Ear, Middle | 2 | 2015 | 9 | 0.140 |
Why?
|
| United States | 7 | 2018 | 4108 | 0.140 |
Why?
|
| Respiratory Tract Infections | 1 | 2018 | 38 | 0.140 |
Why?
|
| Vaccines, Attenuated | 4 | 2018 | 11 | 0.140 |
Why?
|
| Vaccines, Inactivated | 4 | 2018 | 39 | 0.130 |
Why?
|
| Population Surveillance | 2 | 2015 | 128 | 0.130 |
Why?
|
| Body Weight | 1 | 2018 | 301 | 0.120 |
Why?
|
| Models, Theoretical | 2 | 2015 | 138 | 0.120 |
Why?
|
| Overweight | 1 | 2018 | 263 | 0.120 |
Why?
|
| Carnobacteriaceae | 1 | 2015 | 3 | 0.120 |
Why?
|
| Clinical Medicine | 1 | 2015 | 13 | 0.110 |
Why?
|
| Mastoiditis | 1 | 2015 | 2 | 0.110 |
Why?
|
| Mastoid | 1 | 2015 | 2 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2015 | 51 | 0.110 |
Why?
|
| Viral Proteins | 2 | 2004 | 35 | 0.100 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 133 | 0.100 |
Why?
|
| Sneezing | 1 | 2013 | 8 | 0.100 |
Why?
|
| Nasopharynx | 1 | 2013 | 9 | 0.100 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2013 | 11 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 199 | 0.100 |
Why?
|
| Limit of Detection | 1 | 2012 | 15 | 0.100 |
Why?
|
| Cough | 1 | 2013 | 21 | 0.100 |
Why?
|
| Viral Load | 1 | 2013 | 73 | 0.100 |
Why?
|
| Gram-Positive Cocci | 1 | 2012 | 4 | 0.100 |
Why?
|
| Cross Infection | 1 | 2013 | 56 | 0.090 |
Why?
|
| Postpartum Period | 1 | 2012 | 37 | 0.090 |
Why?
|
| Rotavirus Vaccines | 1 | 2012 | 6 | 0.090 |
Why?
|
| Rotavirus Infections | 1 | 2012 | 9 | 0.090 |
Why?
|
| Tonsillitis | 1 | 2012 | 6 | 0.090 |
Why?
|
| Palatine Tonsil | 1 | 2012 | 8 | 0.090 |
Why?
|
| Streptococcus pyogenes | 1 | 2012 | 16 | 0.090 |
Why?
|
| Streptococcal Infections | 1 | 2012 | 20 | 0.090 |
Why?
|
| Health Personnel | 1 | 2013 | 130 | 0.090 |
Why?
|
| Program Evaluation | 1 | 2012 | 181 | 0.090 |
Why?
|
| Nasal Mucosa | 1 | 2011 | 18 | 0.090 |
Why?
|
| Health Policy | 1 | 2012 | 93 | 0.090 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 576 | 0.080 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2012 | 175 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 881 | 0.080 |
Why?
|
| Pregnancy | 1 | 2012 | 981 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2012 | 360 | 0.070 |
Why?
|
| Virus Replication | 2 | 2004 | 42 | 0.070 |
Why?
|
| Alaska | 1 | 2007 | 2 | 0.070 |
Why?
|
| Inuits | 1 | 2007 | 2 | 0.070 |
Why?
|
| Serotyping | 1 | 2007 | 19 | 0.070 |
Why?
|
| Indians, North American | 1 | 2007 | 110 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2018 | 876 | 0.060 |
Why?
|
| Animals | 3 | 2014 | 7569 | 0.060 |
Why?
|
| Gene Products, gag | 1 | 2005 | 2 | 0.060 |
Why?
|
| Adaptor Protein Complex 3 | 1 | 2005 | 2 | 0.060 |
Why?
|
| Virus Assembly | 1 | 2005 | 4 | 0.060 |
Why?
|
| Endosomes | 1 | 2005 | 12 | 0.060 |
Why?
|
| RNA Replicase | 1 | 2004 | 1 | 0.060 |
Why?
|
| HIV-1 | 1 | 2005 | 45 | 0.060 |
Why?
|
| Rhadinovirus | 1 | 2004 | 4 | 0.060 |
Why?
|
| Reoviridae | 1 | 2003 | 2 | 0.050 |
Why?
|
| Inclusion Bodies, Viral | 1 | 2003 | 4 | 0.050 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2003 | 5 | 0.050 |
Why?
|
| Bacterial Capsules | 1 | 2002 | 4 | 0.050 |
Why?
|
| Antigens, Bacterial | 1 | 2002 | 16 | 0.050 |
Why?
|
| Vaccines, Conjugate | 1 | 2002 | 17 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2017 | 3438 | 0.040 |
Why?
|
| Nose | 1 | 2018 | 12 | 0.040 |
Why?
|
| Seasons | 1 | 2018 | 89 | 0.030 |
Why?
|
| Pharynx | 1 | 2017 | 14 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 4032 | 0.030 |
Why?
|
| Acute Disease | 1 | 2018 | 259 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 783 | 0.030 |
Why?
|
| Suppuration | 1 | 2015 | 6 | 0.030 |
Why?
|
| Penicillins | 1 | 2015 | 11 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2015 | 79 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 2015 | 43 | 0.030 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2004 | 5 | 0.030 |
Why?
|
| Precipitin Tests | 2 | 2004 | 14 | 0.030 |
Why?
|
| Hela Cells | 2 | 2005 | 80 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2015 | 3701 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2015 | 223 | 0.030 |
Why?
|
| Gastroenteritis | 1 | 2012 | 12 | 0.020 |
Why?
|
| Healthy People Programs | 1 | 2012 | 3 | 0.020 |
Why?
|
| Tonsillectomy | 1 | 2012 | 10 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2012 | 29 | 0.020 |
Why?
|
| Biofilms | 1 | 2012 | 23 | 0.020 |
Why?
|
| Electronic Mail | 1 | 2012 | 18 | 0.020 |
Why?
|
| Aged | 2 | 2015 | 10538 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2012 | 94 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 90 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 91 | 0.020 |
Why?
|
| Social Behavior | 1 | 2012 | 64 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2012 | 186 | 0.020 |
Why?
|
| Recurrence | 1 | 2012 | 282 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 459 | 0.020 |
Why?
|
| Universities | 1 | 2012 | 153 | 0.020 |
Why?
|
| Obesity | 1 | 2018 | 1152 | 0.020 |
Why?
|
| Internet | 1 | 2012 | 201 | 0.020 |
Why?
|
| Students | 1 | 2012 | 179 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2008 | 16 | 0.020 |
Why?
|
| Age Factors | 1 | 2009 | 1197 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2008 | 412 | 0.010 |
Why?
|
| Adaptor Protein Complex delta Subunits | 1 | 2005 | 1 | 0.010 |
Why?
|
| Transport Vesicles | 1 | 2005 | 2 | 0.010 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2005 | 37 | 0.010 |
Why?
|
| Protein Transport | 1 | 2005 | 72 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2005 | 36 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 96 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 2004 | 10 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2009 | 1844 | 0.010 |
Why?
|
| Protein Binding | 1 | 2005 | 200 | 0.010 |
Why?
|
| Rabbits | 1 | 2004 | 192 | 0.010 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2003 | 5 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2003 | 15 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 184 | 0.010 |
Why?
|
| Cell Line | 1 | 2003 | 433 | 0.010 |
Why?
|
| Mice | 1 | 2003 | 2511 | 0.010 |
Why?
|